228
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Resources and Productivity in Radiation Oncology in Denmark, Finland, Iceland, Norway and Sweden During 1987

, , , &
Pages 555-561 | Received 24 Jan 1990, Accepted 28 Oct 1990, Published online: 08 Jul 2009
 

Abstract

Data concerning megavoltage equipment and use of mega-voltage external beams in cancer management during 1987 in Denmark, Finland, Iceland, Norway, and Sweden were collected from all 37 centres serving a population of 23 million in these countries. Population per Linear Accelerator Equivalent (LAE) unit ranged from 0.30 million/LAE unit (Denmark) to 0.19 million/LAE unit (Sweden). the number of field treatments were 227 548 (Denmark), 259 917 (Finland), 10 426 (Iceland), 147 960 (Norway) and 490 126 (Sweden). the number of field treatments per million population per year ranged from 35 229 (Norway) to 58 438 (Sweden). the number of field treatments per LAE unit/year ranged from 13 192 (Denmark) to 9 546 (Norway). the fraction of cancer patients receiving megavoltage radiotherapy in 1987 out of all newly diagnosed cancer patients during 1987 was 24% in Denmark, 37% in Iceland, 25% in Norway, and 34% in Finland and Sweden. We conclude that Denmark and Norway probably did not provide adequate levels of radiotherapy for their cancer patients during 1987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.